A new trading day began on Tuesday, with Metagenomi Inc (NASDAQ: MGX) stock price up 4.21% from the previous day of trading, before settling in for the closing price of $2.61. MGX’s price has ranged from $1.61 to $12.74 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 3569.20% over the past five years. Meanwhile, its annual earnings per share averaged 87.64%. With a float of $18.78 million, this company’s outstanding shares have now reached $37.43 million.
Let’s look at the performance matrix of the company that is accounted for 236 employees. In terms of profitability, gross margin is 93.13%, operating margin of -160.63%, and the pretax margin is -137.13%.
Metagenomi Inc (MGX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Metagenomi Inc is 49.81%, while institutional ownership is 24.96%. The most recent insider transaction that took place on Dec 05 ’24, was worth 2,900. In this transaction Chief Financial Officer of this company sold 1,559 shares at a rate of $1.86, taking the stock ownership to the 61,492 shares. Before that another transaction happened on Sep 05 ’24, when Company’s Chief Financial Officer sold 6,265 for $2.88, making the entire transaction worth $18,043. This insider now owns 63,051 shares in total.
Metagenomi Inc (MGX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.69 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 87.64% per share during the next fiscal year.
Metagenomi Inc (NASDAQ: MGX) Trading Performance Indicators
Here are Metagenomi Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.50, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.66 in one year’s time.
Technical Analysis of Metagenomi Inc (MGX)
Metagenomi Inc (NASDAQ: MGX) saw its 5-day average volume 1.63 million, a positive change from its year-to-date volume of 1.09 million. As of the previous 9 days, the stock’s Stochastic %D was 7.44%. Additionally, its Average True Range was 0.35.
During the past 100 days, Metagenomi Inc’s (MGX) raw stochastic average was set at 33.53%, which indicates a significant increase from 11.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.52% in the past 14 days, which was lower than the 152.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.79, while its 200-day Moving Average is $4.07. Nevertheless, the first resistance level for the watch stands at $2.79 in the near term. At $2.86, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.98. If the price goes on to break the first support level at $2.60, it is likely to go to the next support level at $2.48. The third support level lies at $2.41 if the price breaches the second support level.
Metagenomi Inc (NASDAQ: MGX) Key Stats
With a market capitalization of 101.79 million, the company has a total of 37,424K Shares Outstanding. Currently, annual sales are 44,760 K while annual income is -68,260 K. The company’s previous quarter sales were 11,510 K while its latest quarter income was -18,770 K.
